Catalyst Health Solutions acquires Walgreens Wellness Initiatives Catalyst Health Solutions, Inc. today announced it provides completed its acquisition of Walgreens’ pharmacy benefit management subsidiary, Walgreens Health Initiatives, Inc. . Catalyst funded the transaction with a combination of cash readily available and amounts obtainable under its credit facility. ‘We’ve been happy with the integration planning and are highly self-confident that the Company will quickly realize the many strategic and financial great things about this transaction,’ stated David T. Blair, Chief Executive Officer of Catalyst. THE BUSINESS will issue another press release and conduct a special investor conference ask July 7, 2011 to further discuss the WHI acquisition and provide updated 2011 financial guidance.They are just useful for six months or less of treatment. Progesterone-receptor modulators block the actions of the ovarian hormone progesterone and lower fibroid symptoms and reduce fibroid volume but are currently not available in the United States. Uterine artery embolization, a minimally invasive interventional radiologic technique that is shown in randomized trials to bring about quality of life that is similar to that after medical procedures, with shorter hospital stays and less period to resumption of typical activities. MRI-guided, focused ultrasound medical procedures, a fibroid-particular therapy that uses ultrasound thermal ablation to treat fibroids without incisions no hospital stay.